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Background: Three neuropeptides, gastrin releasing peptide (GRP), natriuritic precursor peptide B (NPPB), and
neuromedin B (NMB) have been proposed to play roles in itch sensation. However, the tissues in which these
peptides are expressed and their positions in the itch circuit has recently become the subject of debate. Here we
used next-gen RNA-Seq to examine the expression of transcripts coding for GRP, NPPB, NMB, and other peptides in
DRG, trigeminal ganglion, and the spinal cord as well as expression levels for their cognate receptors in these tissues.
Results: RNA-Seq demonstrates that GRP is not transcribed in mouse, rat, or human sensory ganglia. NPPB, which
activates natriuretic peptide receptor 1 (NPR1), is well expressed in mouse DRG and less so in rat and human, whereas
NPPA, which also acts on the NPR1 receptor, is expressed in all three species. Analysis of transcripts expressed in the
spinal cord of mouse, rat, and human reveals no expression of Nppb, but unambiguously detects expression of Grp and
the GRP-receptor (Grpr). The transcripts coding for NMB and tachykinin peptides are among the most highly expressed
in DRG. Bioinformatics comparisons using the sequence of the peptides used to produce GRP-antibodies with proteome
databases revealed that the C-terminal primary sequence of NMB and Substance P can potentially account for results
from previous studies which showed GRP-immunostaining in the DRG.
Conclusions: RNA-Seq corroborates a primary itch afferent role for NPPB in mouse and potentially NPPB and NPPA in rats
and humans, but does not support GRP as a primary itch neurotransmitter in mouse, rat, or humans. As such, our results
are at odds with the initial proposal of Sun and Chen (2007) that GRP is expressed in DRG. By contrast, our data strongly
support an itch pathway where the itch-inducing actions of GRP are exerted through its release from spinal cord neurons.
Keywords: Pruritis, Bombesin, Ranatensin, GRP, GRPR, NMB, NMBR, Tac1, Nppa, Nppb, Nppc, Npr1, Npr2, Npr3, RNA-Seq,
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reactionIntroduction
The concept of a specific circuit for the sensation of itch
received a strong impetus from two papers in 2007 and
2009 [1,2]. These studies described how gastrin releasing
peptide (GRP) can specifically cause scratching behavior
which is lost upon genetic or pharmacological elimination
of the GRP-receptor or GRP-receptor bearing second* Correspondence: michael.iadarola@nih.gov
1Department of Perioperative Medicine, Building 10, Room 2C401, MSC 1510,
Clinical Center, NIH, 10 Center Drive, Bethesda, MD 20892, USA
Full list of author information is available at the end of the article
© 2014 Goswami et al.; licensee BioMed Centr
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.order neurons in the spinal cord. The behavior evoked by
GRP was claimed to be due to the release of this peptide
from primary afferents which in turn was proposed to
cause the activation of GRP-receptor-bearing neurons in
the spinal cord dorsal horn [1,2]. Recently, however the
expression of GRP in DRG has been disputed [3,4] and a
role for another neuropeptide, natriuretic precursor pep-
tide B (NPPB), in provoking scratching behavior was de-
lineated in mice [4]. Additionally, the capacity for a third
neuropeptide, neuromedin B (NMB) to evoke scratching
behaviors has been suggested [5].al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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pression of Grp, Nppb, and Nmb and their receptors in
DRG and spinal cord through application of RNA-Seq.
This method has several notable advantages over other
techniques such as gene-array, RT-PCR and in situ
hybridization (ISH). First, RNA-Seq uses next-generation
DNA sequencing to determine every mRNA transcript
in a particular sample. Since each sequenced cDNA frag-
ment can be counted, the resulting data are quantitative.
Second, because the association of transcript fragments
to a particular gene is based on exact sequence align-
ment, rather than hybridization, gene identification is
exquisitely precise. Third, the presence of rare tran-
scripts can be captured by adjusting the depth of se-
quencing, thereby providing a rigorous measurement
for all, or nearly all, expressed genes in a sample.
These properties allowed us to accurately assess the
expression level of Nppb, Grp, and Nmb and their
cognate receptors.
For sensory ganglia, we examined expression in mouse
and rat DRG, and mouse, rat and human trigeminal gan-
glia. We also determined expression of these genes in
mouse, rat and human spinal cord. For mouse DRG, a
genetic labeling strategy was used to isolate neurons of
the transient receptor potential family V, member 1
(TRPV1) lineage and the non-TRPV1 lineage [6]. The
latter DRG preparation consists of neurons remaining
following ablation of neurons in the TRPV1-lineage. The
neuropeptides GRP, NPPB and NMB co-localize with
TRPV1-expressing cells or the TRPV1-lineage of noci-
ceptive neurons [7]. Furthermore, it has been shown that
the TRPV1-lineage neurons are absolutely required for
pruritic responses [4]. These two preparations were ex-
tensively sequenced (~172 million paired end reads) to
reveal transcripts expressed even at very low levels.
Thus, the depth of sequencing combined with our gen-
etic enrichment strategy enhances the chances of identi-
fying rare transcripts in mouse DRG, including those for
Grp. Importantly, for comparison we also provide data
on a class of mouse sensory neurons not required for
itch-behavior (the non-TRPV1 transcriptome). In all
other cases, we sequenced the entire DRG or trigeminal
ganglion to a lower extent (~40 million paired end
reads) which is sufficient to detect low expressed genes.
Our results demonstrate that mouse, rat, and human
sensory neurons express natriuretic peptides capable of
activating NPR1, while a role for GRP as a primary affer-
ent itch neurotransmitter is not supported.
Methods
Animal and human tissues
The mouse and rat PNS and CNS tissues analyzed in
this study were obtained under protocols approved by
the institutional Animal Care and Use Committees of theNational Institute of Dental and Craniofacial Research
and the Clinical Center, NIH. The human trigeminal gan-
glia and spinal trigeminal nucleus caudalis tissues were
collected as part of the National Institute of Mental
Health Brain Bank program.
RNA sources
Mouse TRPV1 lineage and non-TRPV1 lineage DRG RNA
samples were obtained from BAC-TRPV1 promoter-Cre
mice as described (Mishra et al., 2011). Total RNA was ex-
tracted using the RNeasy Mini kit (Qiagen Inc., Valencia,
CA, USA) and the RNA integrity was assessed by gel elec-
trophoresis on an Agilent Bioanalyzer. Samples with a
RNA integrity number (RIN) above 8.5 were sequenced
from individual rat DRG (N= 9), rat DH (N = 3), rat TG
(N = 3), mouse DRG lineage preparations (N = 2), mouse
DH (N= 4), mouse TG (N = 3), human TG (N = 2) and
human DH (N = 3). N represents individual samples; for
the individual rat DRG samples, we pooled L4, L5 and for
the individual mouse TG samples, both TGs were pooled.
Values are reported as average ± SEM RPKM where three
or more samples are available. Rat and mouse spinal cord
were dissected from the dorsal half of the lumbar enlarge-
ment and human spinal cord RNA was prepared from the
trigeminal nucleus caudalis at the level of the pyramidal
decussation. Next-Gen Sequencing was performed on
cDNA from poly A+ selected mRNA using the Illumina
HiSeq2000 platform using version 3 chemistry according
to standard protocols. For the TRPV1-lineage and non-
TRPV1 lineage neuronal preparations, 166 and 178
million paired end reads of 101 bases were obtained,
respectively; all other datasets were sequenced to ~40 mil-
lion paired end reads of 101 bases. We also analyzed
RNA-Seq data for rat DRG from in-silico data deposited
by Hammer et al. (2010) in conjunction with their spinal
nerve ligation study [8].
RNA-Seq
Quality control was performed on all raw sequence data
using FastQC (version 0.10.0). The minimum FastQC
score for all the datasets was above or equal to 28 and
therefore no further preprocessing was done. The se-
quences were aligned and mapped with RNA-Seq unified
mapper (RUM v2.05) [9]. Gene annotations from Ref-
seq, UCSC and ENSEMB were used within RUM. To
account for variability in expression values between
mapping algorithms, all the samples were remapped
with another tool, MAGIC <ftp://ftp.ncbi.nlm.nih.gov/
repository/acedb/Software/Magic>, which uses the AceDB
for genome annotation <http://www.acedb.org/index.
shtml>. Data values are presented as Reads Per Kilobase
of exon model per Million mapped reads (RPKM), a
normalization which takes into consideration the length
of coding exons of genes and depth of sequencing [9].
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Considering that Grp is not expressed in DRG, we con-
ducted a proteomic-bioinformatic search to formally ad-
dress the question of: What peptides are similar enough
to GRP to account for the immunoreactive material in
DRG neurons observed by immunofluorescence [1]? We
focused on peptides with C-termini similar to GRP be-
cause many studies use antisera generated to the
carboxy-end of the 14 AA amphibian peptide bombesin
(pGlu-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-
Met-NH2). C-terminal amidation is known to proceed via
the enzyme peptidylglycine α-amidating monooxygenase
(PAM), which cuts the precursor polypeptide such that
the nitrogen atom from an adjacent glycine residue is
transferred to the amidated amino acid [10,11]. In the pre-
cursor, the glycine is usually followed by paired basic
residues typical of peptide-containing polyproteins. Specif-
ically, based on these considerations we used the ProSite
tool to search the SwissProt portion within the UniProtKB
database for the following sequences GHLMG(KR)(KR),
HLMG(KR)(KR), or XMG(KR)(KR). These search entries
contain the cryptic peptide sequence motifs required
for the C-terminal amidation resulting in a C-terminal
methionine-amide.
Results
Dorsal root and trigeminal ganglia
Neuropeptide expression in dorsal root/trigeminal ganglia
Our RNA-Seq analysis employed both RUM and MAGIC
which yielded similar results. For simplicity, data acquiredTable 1 Neuropeptide and receptor expression in dorsal root
Dorsal root ganglion








Nmb, neuromedin B 170.3 73.7
Nmbr, neuromedin B receptor 0.1 0.1
Nppa, natriuretic peptide A; ANF 1.5 1.2
Nppb, natriuretic peptide B; BNP 24.1 0.2










Tac1, protachykinin-1 597.7 14.1
The values in the table are average expression levels (and where applicable ± SEM) in
Reads Per Kilobase of exon model per Million mapped reads, a normalization which ta
sequencing [9]. The mouse DRG dataset consists of TRPV1 lineage and non-TRPV1 line
described (Mishra et al., 2011) [6]. Annotation builds mm10, rn4, and hg19 were used, r
values of 20 reads or below; this number of reads is too inaccurate for further considerby RUM are presented (Tables 1 and 2). Results obtained
from analysis of DRG (mouse and rat), and TG (mouse,
rat, and human) show that Grp is not expressed in pri-
mary sensory neurons (Table 1). We base this conclusion
on the fact that no raw reads for Grp transcripts were
detected in mouse or rat DRG preparations with RUM
or MAGIC. We also analyzed a completely independent
data by Hammer et al. (2010), which also showed no
GRP expression in DRG (not shown). In the aggregate,
we have analyzed 17 DRG or TG samples from three
species, as well as the Hammer dataset. With this large
number of samples, it is highly unlikely that the lack of
observable Grp expression is due to sample under-
representation or to species-specific differences in expres-
sion of Grp.
In contrast to GRP, we found that three other neuro-
peptides are highly expressed in mouse DRG and TG
(Table 1). Specifically in TRPV1 lineage-neurons, the
RPKM values for Tac1 (coding for substance P), Nmb,
and Nppb were 597.7, 170.3, and 24.1, respectively. In
contrast, Nppb was virtually absent in non-TRPV1-
neurons whereas Tac1 and Nmb showed some overlap.
NMB, Substance P and NPPB have been implicated as
mediators of nociceptive processes [4,7,12]. The itch-
specific neurotransmitter NPPB has two other paralogs
NPPA and NPPC. Nppa is expressed at 5.1 RPKM in rat
DRG, and approximately 1 RPKM in mouse and human
sensory neurons. On the other hand, Nppc is expressed
below 0.5 RPKM in mouse, rat, and human sensory










- - - 0.1
- 0.3 ± 0 0.1 ± 0 0.1
32.6 ± 4.49 16.5 ± 0.9 13.0 ± 0.3 7.5
0.2 ± 0.02 0.1 ± 0 0.3 ± 0 0.2
5.1 ± 0.73 1.0 ± 0.1 0.8 ± 0.1 1.8
0.7 ± 0.14 2.0 ± 0.1 - 0.8
- 0.1 ± 0 0.1 ± 0 0.4
0.8 ± 0.06 1.2 ± 0 0.9 ± 0 0.9
31.7 ± 0.85 35.4 ± 0.4 36.7 ± 0.8 15.3
4.1 ± 0.44 2.6 ± 0.1 4.3 ± 0.5 0.3
140.3 ± 10.92 59.8 ± 2.84 122.2 ± 4.9 44.1
RPKM of itch related neuropeptides and their receptors. RPKM is an acronym for
kes into consideration the length of coding exons of genes and depth of
age RNA samples which were obtained from BAC-TRPV1 promoter-Cre mice as
espectively, for the mouse, rat and human genome mapping. Dashes (−) represent
ation.
Table 2 Neuropeptide and receptor expression in dorsal spinal cord
Dorsal spinal cord
Gene symbol and gene name Mouse RPKM Rat RPKM Human RPKM
Grp, gastrin-releasing peptide 1.58 ± 0.71 2.09 ± 0.33 2.93 ± 0.39
Grpr, gastrin releasing peptide receptor 1.34 ± 0.15 0.94 ± 0.10 0.38 ± 0.03
Nmb, neuromedin B 1.28 ± 0.16 0.51 ± 0.08 2.70 ± 0.29
Nmbr, neuromedin B receptor 1.97 ± 0.11 2.02 ± 0.27 2.71 ± 0.72
Nppa, natriuretic peptide A; ANF 0.26 ± 0.03 1.21 ± 0.22 1.02 ± 0.07
Nppb, natriuretic peptide B; BNP 0.02 ± 0.01 0.01 ± 0.01 0.85 ± 0.21
Nppc, natriuretic peptide C; CNP 4.64 ± 0.66 3.61 ± 0.71 54.83 ± 9.74
Npr1, natriuretic peptide receptor 1; Npra 1.75 ± 0.17 5.94 ± 0.46 0.19 ± 0.05
Npr2, natriuretic peptide receptor 2; Nprb 12.46 ± 0.30 19.97 ± 4.90 5.79 ± 0.36
Npr3, natriuretic peptide receptor 3; Nprc 0.77 ± 0.08 0.81 ± 0.13 0.05 ± 0.01
Tac1, protachykinin-1 14.74 ± 1.55 16.14 ± 3.27 70.25 ± 7.60
Average expression levels (±SEM) in dorsal spinal cord of itch-related neuropeptides and their receptors for mouse, rat and human are shown. Detectable expression of
Grp, Grpr, Nmb, and Nmbr is seen in all three species. Tac1 is well expressed in spinal cord tissue [24], especially in the human. RPKM levels were determined by Rapid
Unified Mapper (RUM) [9]. Annotation builds mm10, rn4, and hg19 were used, respectively, for the mouse, rat and human genome mapping. Dashes (−) represent
values of 20 reads or below; this number of reads is too inaccurate for further consideration.
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In mouse, rat and human DRG and TG, the receptors
for GRP and NMB are expressed at very low levels (0.1-
0.3 RPKM, Table 1). Generally, this level of expression is
not considered to be functionally relevant. The NPR1 re-
ceptor, which binds natriuretic peptides NPPA and
NPPB [13,14], is expressed at very low levels in sensory
neurons (0.7-1.2 RPKM for mouse, rat and human DRG
and TG). NPR3, the scavenger receptor for all the natri-
uretic peptides [14], shows a more variable distribution
of expression, ranging between 0.1 and 4.3 RPKM in
mouse, rat and human DRG and TG. In contrast, the re-
ceptor for NPPC, NPR2 [14], is highly expressed in all
ganglia and species.
Spinal cord
Neuropeptide expression in spinal cord
The fact that we did not detect Grp expression in DRG
is not because RNA-Seq lacks the sensitivity to detect
the transcript for Grp as we readily measured its expres-
sion in the dorsal spinal cord of mouse, rat and human
(average of 2.2 RPKM). Grp is expressed at a similar
level to Nmb in the spinal cord (1.59 RPKM average in
the three species). In contrast, Nppb is not expressed or
is only expressed at trace levels (~0.01 RPKM) in mouse
and rat dorsal spinal cord and is low (~0.85 RPKM) in
human dorsal spinal cord. The other two genes in the
natriuretic peptide family, Nppa and Nppc are both
expressed in dorsal spinal cord, with Nppc being
expressed at a higher level, approximately 4 RPKM in
mouse and rat and substantially greater in human (54.8
RPKM). A species difference is also seen for Nppa, with
the lowest expression level (0.26 RPKM) in mouse and
slightly higher expression (~1.1 RPKM) in rat andhuman. These data suggest that NPPA and NPPC may
both participate in some aspects of sensory modulation.
Neuropeptide receptor in spinal cord
The receptor for GRP is expressed in dorsal spinal cord
at approximately similar levels in mouse and rat (average
of 1.1 RPKM). Lower levels are seen in human 0.38
RPKM. NMB receptors are expressed at a slightly higher
level (average of 2.23 RPKM) compared to the GRP re-
ceptors, and levels are similar across mouse, rat and hu-
man. For the natriuretic peptide receptor, NPR2, mice,
rats, and humans have RPKM values of 12.5, 20, and 5.8,
respectively. Transcript levels of Npr1 and Npr3 are
comparatively less in the spinal cord. Npr1 is expressed
at an average of 3.85 RPKM in mouse and rat and 0.19
RPKM in human and Npr3 is expressed at an average of
0.79 RPKM in mouse and rat and at trace level (0.05
RPKM) in human. While the lumbar dorsal spinal cord
was dissected in mouse and rat, we note that our human
samples were collected from a more rostral level (spinal
trigeminal nucleus at the decussation of the pyramidal
tract) than in the rat or mouse. This difference in
rostro-caudal level may account for some of the differ-
ences in transcript expression observed between species.
Bioinformatic identification of GRP-like peptides
Previously, it has been suggested from immunohistogical
studies that Grp is expressed in sensory ganglia [1,2].
We asked whether the difference between these immuno-
histochemical observations and our quantitative RNA-Seq
analysis could be attributed to cross-reaction of antibodies
with other neuropeptides. A bioinformatics approach was
devised to search for possible peptide sequences that may
cross-react with C-terminally directed bombesin/GRP-
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sequences, GHLMG(KR)(KR) and HLMG(KR)(KR) be-
cause they contain the cryptic C-terminal amidation signal
[10,11]. This stringent search yielded matches only to
bombesin and GRP (Figure 1A). When we reduced the
stringency to XMG(KR)(KR) we obtained matches to
~300 proteins. Searching this data set for neuropeptides
that are expressed in DRG and TG, we found matches to
two neuropeptides, NMB and Substance P as well as
matches to peptide analogs isolated from frog skin
(Figure 1A) [15]. These data raise the possibility that
NMB and/or substance P may cross react with C-terminally
directed anti-bombesin/Grp antibodies. This possibility is
strongly supported by the very high expression of theseFigure 1 Evaluation of sequences and cross reaction of GRP/bombesin re
Tachykinin and amphibian peptide orthologs. The table depicts amino acid seq
nlm.nih.gov/protein]. There is conservation of sequence across human, mouse a
100% sequence identity which is: VSTGAGGGTVLAKMYPRGSHWAVGHLM (differe
binding figure is reproduced with permission from Panula et al. (1982) [27]. It exa
with bombesin, ranatensin, substance P and eledoisin (an amphibian peptide sim
Neuromedin B and fully displaces the iodinated bombesin tracer. Substance P istwo peptides in DRG and had been proposed in an earlier
study [3]. In fact, our RNA-Seq data disclose enormously
high level of Nmb and Tac1 (Substance P-containing)
transcripts (170 and 597 RPKM, respectively; Table 1)
which could act as rich targets for antibody cross-
reactivity.
Discussion
The understanding of the neurobiology of itch has pro-
gressed considerably over the last 5 years with the identifi-
cation of a number of neuropeptides critical for itch-
responses. Gene knockout, cell deletion, pharmacological,
and immunohistochemical or in situ hybridization data
have been assembled to delineate the functions andlated neuropeptides. A: Amino acid sequence comparison of GRP, NMB,
uences obtained from human and amphibian sources [http://www.ncbi.
nd rat species for all peptides other than GRP. Mouse and rat GRP share
nces from the human sequence are highlighted in red). B: The competitive
mines the cross-reaction of a C-terminally directed anti-bombesin antiserum
ilar to substance P). Ranatensin shares C-terminal sequence similarity with
just beginning to displace the tracer at the concentrations used.
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NPPB, and NMB, in the primary afferent-spinal cord cir-
cuit. Several recent studies have emphasized a primary af-
ferent role for NPPB [4] and NMB [3] in itch and
deemphasized a primary afferent role for GRP [3,4]. More
recently still, a primary afferent role for GRP has been re-
emphasized [16]. To address this controversy directly, we
analyzed expression levels of these neuropeptides in
mouse, rat and human DRG/TG and dorsal spinal cord
using RNA-Seq. The RNA-Seq methodology provides un-
equivocal gene identification and exact quantification of
gene expression, even when a gene is expressed at very
low levels. We also used these data to examine expression
levels of all the relevant receptor paralogs that might be
expressed in mouse, rat and human DRG/TG and dorsal
spinal cord to obtain a complete expression profile within
the neuronal circuit and across species.
Deep sequencing, in combination with a FACS strat-
egy for enrichment of the TRPV1 neuronal lineage
population, a subset of sensory neurons which are
known to be required for pruritic responses [4], did not
detect Grp transcripts. Furthermore, analyses of mul-
tiple whole rat DRG/TG and human TG samples did
not identify Grp transcripts. Thus, our RNA-Seq ana-
lyses indicate an absence of Grp expression in DRG and




The present quantitative RNA-Seq data indicates no ex-
pression of GRP in mouse, rat or human DRG/TG. An
earlier in situ hybridization investigation also detected
abundant expression of Nmb but no expression of Grp
in rat DRG [17]. More recently two additional studies,
also using ISH, failed to detect Grp in mouse DRG [3,4].
Furthermore, RT-PCR of DRG cDNA amplified either
no or, only trace, amounts of Grp [3,4]. Taken together
and viewed together with the perspective of our RNA-
Seq measurements, these data strongly suggest that any
equivocal observations of Grp expression in DRG are
likely false positive results. While we cannot be certain
of the reasons for false positives, possible explanations
might include trace contamination of PCR primer sets
or template preparations [18] or over-development of
histochemical reactions.
It is important to note that expression of transcripts
may differ in preparations that have been manipulated
such as after ganglionic dissociation for primary cultures
or transgenic manipulations. For example, primary
mouse DRG cultures have been reported to express
Npr3 whereas our RNA-Seq results from freshly dis-
sected DRG tissue show quite low expression [19]. Over
expression of Braf has also been reported to induce Grpexpression in DRG [16]. Manipulations of afferent trans-
mission by tissue inflammation or direct nerve injury
may also cause altered expression, however, preliminary
results obtained in rat from our RNA-Seq data after
axotomy or hind paw inflammation do not show an in-
duction of Grp or Grp-receptor in DRG.
The quantitative data for transcripts coding for GRP,
NPPB, and NMB are presented in Table 1. Examination
of these data across species indicates that Nppb, while
well expressed in mouse, is expressed at a relatively low
level in rat and human DRG/TG. In its place, the close
family member, Nppa is expressed. Therefore, it is
tempting to speculate that the rat and human itch circuit
may utilize the same natriuretic-receptor (NPR1) as is
used by mice, but instead of using NPPB, may use NPPA
as a primary afferent itch co-transmitter. Nmb is ex-
pressed at high levels in mouse, rat and human DRG/
TG suggesting an important conserved nociceptive func-
tion for this neuropeptide.
Spinal cord
The RNA-Seq results obtained from dorsal spinal cord
illustrate the plethora of receptors and neuropeptides
that are present in the neurons that integrate somato-
sensory signals. In the spinal cord, we detected expres-
sion of Grp, Grp-receptor (Grpr), Nmb, Nmb-receptor
(Nmbr), Nppa and Nppc and the natriuretic receptors 1,
2 and 3. By contrast, there was almost no expression of
Nppb. The present data are consistent with behavioral
results obtained by intrathecal injections of various itch-
inducing peptides, but do not necessarily clarify issues of
circuitry or co-localization [19-22]. While we demonstrate
the presence of the relevant molecular substrates, it is be-
yond the scope of the present study to critically evaluate
behavioral results from earlier studies [1,2,4-7,16,19,23].
However, our results are consistent with most avail-
able neuroanatomical studies examining these targets
in DH [4,17,24].
The RNA-Seq results also clarify the expression of cer-
tain receptors whose presence in spinal cord might have
been difficult to interpret based on in situ hybridization
or RT-PCR methods. The detection of Nmb and Nmb
receptor (Nmbr) expression at levels approximately equal
to Grp and Grp receptor (Grpr) expression suggests that
the inability to detect Nmb and Nmbr in the dorsal spinal
cord might be due to technical reasons [17]. Thus, the ex-
pression of multiple itch-related neuropeptides and their
cognate receptors in the spinal cord along with evidence
of NMB binding to the GRP receptor and GRP binding to
the NMB receptor, albeit to a low affinity [22,25], allows
for many plausible itch receptor-ligand interactions in this
CNS region, and emphasizes issues related to dose–
response in experimental design. These quantitative
considerations can also be informative for further
Goswami et al. Molecular Pain 2014, 10:44 Page 7 of 8




Based on our RNA-Seq results we examined what might
account for previous immunostaining reports that de-
scribe GRP-containing neurons in DRG [1,2]. Searches
for sequences with similar primary structure to the anti-
gen used to produce anti-bombesin/GRP antibodies re-
vealed two candidates that can cross-react, NMB and
Substance P. Both of these peptides are present in very high
quantities in DRG neurons. Previously the immunocross-
reactivity of various peptides has been examined for their
potencies to displace [125I] bombesin from a C-terminally
directed antibody (See Figure 1B; reproduced with permis-
sion from Panula et al., 1982) [27]. This study shows that,
although the binding of ranatensin/NMB and substance P
is far lower than that for Bombesin/GRP (between 10- to
200-fold, respectively), with sufficient peptide, full dis-
placement of 125I-bombesin tracer can be obtained, espe-
cially for NMB, and with extrapolation, also for substance
P [27]. The antibody used by Sun et al., and Chen et al.,
was a C-terminally directed anti-bombesin antibody,
therefore the most plausible explanation for the discrete
immunostaining of DRG neuronal cell bodies in these
studies appears likely to be cross-reaction with NMB and/
or substance P.
Concluding remarks
Our data indicate that Grp is not expressed in DRG or
TG. A reasonable explanation for immunofluorescent
staining reported for GRP in DRG/TG could be that
anti-GRP antibodies cross-react with Nmb and/or sub-
stance P due to the high levels of expression of the latter
two neuropeptides and to the close primary structure of
their amidated C-termini. As a consequence of this mis-
identification, several types of studies, such as innerv-
ation of the dermis and epidermis [28] and the effects of
bombesin on wound healing, may need reinterpretation
[29,30]. RNA-Seq provides information on gene expres-
sion only, and the fine details of protein turnover, subcel-
lular compartmentalization, and/or localized enrichment
are additional important considerations for integrative
neurobiological research. Nonetheless, RNA-Seq provides
a powerful new method for guiding research and a useful
baseline to begin functional experimentation.
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